These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3286673)

  • 1. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
    Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
    Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
    Paolisso G; Scheen AJ; Giugliano D; Sgambato S; Albert A; Varricchio M; D'Onofrio F; Lefèbvre PJ
    J Clin Endocrinol Metab; 1991 Mar; 72(3):607-15. PubMed ID: 1997515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
    Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
    Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
    Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pulsatile delivery of insulin and glucagon in humans.
    Paolisso G; Scheen AJ; Albert A; Lefebvre PJ
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E686-96. PubMed ID: 2688437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
    Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
    J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
    Komjati M; Bratusch-Marrain P; Waldhäusl W
    Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline.
    Attvall S; Fowelin J; von Schenck H; Smith U; Lager I
    J Clin Endocrinol Metab; 1992 May; 74(5):1110-5. PubMed ID: 1569157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
    Østergård T; Degn KB; Gall MA; Carr RD; Veldhuis JD; Thomsen MK; Rizza RA; Schmitz O
    J Clin Endocrinol Metab; 2004 Jan; 89(1):297-302. PubMed ID: 14715864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
    Asplin CM; Paquette TL; Palmer JP
    J Clin Invest; 1981 Jul; 68(1):314-8. PubMed ID: 7019246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
    Pal BR; Phillips PE; Matthews DR; Dunger DB
    Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine.
    Whittington KB; Solomon SS; Lu ZN; Selawry HP
    Endocrinology; 1991 Jun; 128(6):2671-7. PubMed ID: 1674684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.